Development and validation of a nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session in the era of extended prostate sampling

BJU International

Volumn 106, Issue 9, 2010, Pages 1309-1314

  Moussa, Ayman S ^a   Jones, J Stephen ^a   Yu, Changhong ^a   Fareed, Khaled ^a   Kattan, Michael W ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

biopsy; prostate; prostatic neoplasms; risk biopsy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; ARTICLE; BODY MASS; CANCER DIAGNOSIS; DIAGNOSTIC ACCURACY; DIGITAL RECTAL EXAMINATION; FAMILY HISTORY; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROSTATE; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; REPEAT PROCEDURE; VALIDATION STUDY;

AGED; AGED, 80 AND OVER; BIOPSY; FALSE NEGATIVE REACTIONS; HUMANS; MALE; MIDDLE AGED; NOMOGRAMS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS; ROC CURVE;

EID: 78349270217     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09362.x     Document Type: Article

References (25)

1. Keetch DW, Catalona WJ, Smith DS,. Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J Urol 1994; 151: 1571-4
2. Keetch DW, McMurtry JM, Smith DS, Andriole GL, Catalona WJ., Prostate specific antigen density versus prostate specific antigen slope as predictors of prostate cancer in men with initially negative prostatic biopsies. J Urol 1996; 156: 428-31
3. Fowler JE Jr, Bigler SA, Miles D, Yalkut DA,. Predictors of first repeat biopsy cancer detection with suspected local stage prostate cancer. J Urol 2000; 163: 813-8
4. Djavan B, Zlotta A, Remzi M, et al. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men. J Urol 2000; 163: 1144-8
5. Epstein JI, Potter SR,. The pathological interpretation and significance of prostate needle biopsy findings: implications and current controversies. J Urol 2001; 166: 402-10
6. Vis AN, Hoedemaeker RF, Roobol M, Schroder FH, Van Der Kwast TH., The predictive value for prostate cancer of lesions that raise suspicion of concomitant carcinoma: an evaluation from a randomized, population-based study of screening for prostate cancer. Cancer 2001; 92: 524-34
7. Roehrborn CG, Pickens GJ, Sanders JS,. Diagnostic yield of repeated transrectal ultrasound-guided biopsies stratified by specific histopathologic diagnoses and prostate specific antigen levels. Urology 1996; 47: 347-52
8. Ellis WJ, Brawer MK,. Repeat prostate needle biopsy: who needs it? J Urol, 1995; 153: 1496-8
9. Fleshner NE, O'Sullivan M, Fair WR,. Prevalence and predictors of a positive repeat transrectal ultrasound guided needle biopsy of the prostate. J Urol 1997; 158: 505-8
10. Hong YM, Lai FC, Chon CH, McNeal JE, Presti JC Jr,. Impact of prior biopsy scheme on pathologic features of cancers detected on repeat biopsies. Urol Oncol 2004; 22: 7-10
11. Yanke BV, Gonen M, Scardino PT, Kattan MW,. Validation of a nomogram for predicting positive repeat biopsy for prostate cancer. J Urol 2005; 173: 421-4
12. Harrell FE Jr,. Design: Design Package. R Package, Version 2.1-2. 2008. Available at:. Accessed 28 September 2008
13. Chun FK, Briganti A, Graefen M, et al. Development and external validation of an extended repeat biopsy nomogram. J Urol 2007; 177: 510-5
14. Roehl KA, Antenor JA, Catalona WJ,. Serial biopsy results in prostate cancer screening study. J Urol 2002; 167: 2435-9
15. Zlotta AR, Djavan B, Marberger M, Schulman CC,. Prostate specific antigen density of the transition zone: a new effective parameter for prostate cancer prediction. J Urol 1997; 157: 1315-21
16. Djavan B, Zlotta AR, Byttebier G, et al. Prostate specific antigen density of the transition zone for early detection of prostate cancer. J Urol 1998; 160: 411-8
17. O'Dowd GJ, Miller MC, Orozco R, Veltri RW,. Analysis of repeated biopsy results within 1 year after a noncancer diagnosis. Urology 2000; 55: 553-9
18. Gokden N, Roehl KA, Catalona WJ, Humphrey PA,. High-grade prostatic intraepithelial neoplasia in needle biopsy as risk factor for detection of adenocarcinoma: current level of risk in screening population. Urology 2005; 65: 538-42
19. Park S, Shinohara K, Grossfeld GD, Carroll PR,. Prostate cancer detection in men with prior high grade prostatic intraepithelial neoplasia or atypical prostate biopsy. J Urol 2001; 165: 1409-14
20. Abouassaly R, Tan N, Moussa A, Jones JS,. Risk of prostate cancer after diagnosis of atypical glands suspicious for carcinoma on saturation and traditional biopsies. J Urol 2008; 180: 911-4
21. Lopez-Corona E, Ohori M, Scardino PT, Reuter VE, Gonen M, Kattan MW., A nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session. J Urol 2003; 170: 1184-8
22. Walz J, Graefen M, Chun FK, et al. High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series. Eur Urol 2006; 50: 498-505
23. Benecchi L, Pieri AM, Melissari M, et al. A novel nomogram to predict the probability of prostate cancer on repeat biopsy. J Urol 2008; 180: 146-9
24. Hayek OR, Noble CB, De La Taille A, et al. The necessity of a second prostate biopsy cannot be predicted by PSA or PSA derivatives (density or free: total ratio) in men with prior negative prostatic biopsies. Curr Opin Urol 1999; 9: 371-5
25. Haese A, De La Taille A, Van Poppel H, et al. Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy. Eur Urol 2008; 54: 1081-8